semaglutide biologic A new study from UC San Diego offers early clinical evidence that semaglutide, a widely used GLP-1 receptor agonist, may slow biological aging. In a randomized, placebo-controlled trial, researchers observed a 9% Semaglutide (Rybelsus; Ozempic; NN9535; OG217SC;

Not only is it effective, but its also as close to free as you can get

10.1016/j.molcel.2011.11.009 42 KadykL

For commercially insured patients: Wegovy or Zepbound with a manufacturer savings card at $25 per fill

[DOI] [Google Scholar] 152.Ramoz N., Reichert J.G., Smith C.J., Silverman J.M., Bespalova I.N., Davis K.L., Buxbaum J.D

They found that overexpression of miR-145 led to inhibition of IGF-1-induced cell proliferation and miR-145 was shown to directly bind to 3UTR of IGF-1R and IRS-1 in the bladder cancer cells

In addition, an outline on the therapeutic strategies against antithyroid drugs-induced hepatotoxicity is given here